05/09/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
5:10 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024
5:15 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
03/26/2024
3:05 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/26/2024
3:00 PM | Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/26/2024
3:00 PM | Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
5:13 AM | Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:11 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
01/22/2024
7:19 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:22 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:40 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2023
11:15 PM | Phathom Pharmaceuticals (Filer)
| Form EFFECT | |
11/09/2023
3:02 PM | Phathom Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/09/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:56 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:53 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:54 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:55 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:07 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/21/2023
7:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4/A | |
07/17/2023
4:00 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:00 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:00 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:02 PM | Phathom Pharmaceuticals (Subject)
| Form SC TO-I/A | |
07/17/2023
3:04 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
8:10 AM | Phathom Pharmaceuticals (Subject)
| Form SC TO-C | |
06/15/2023
8:01 AM | Phathom Pharmaceuticals (Subject)
| Form SC TO-I | |
06/15/2023
8:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
5:32 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
How to Make 100X on the AI Boom (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
06/05/2023
5:37 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:46 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:48 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:53 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:55 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:57 PM | Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
6:01 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
6:03 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
4:16 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
4:29 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/24/2023
3:11 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
05/24/2023
3:14 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
3:47 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
05/23/2023
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
11:15 AM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
